Our Services
Clinical study conception & Management: IS/NIS/RWE
-
- Development of “Concept” protocol
- Medical Writing
- Project Management/coordination
- Investigators selection
- Site feasibility
- Submission and obtention of regulatory approvals
- Organization and animation of investigator meetings
- Site initiation, periodic monitoring and site close-out visits
- Data entry/support visit (Tecking)
- Management of study vigilance
- Management of health products: TUs, MDs,…
- Management of study materials: tablets, connected devices, questionnaires…
- Data Management
- Statistics
- Payment of investigator and hospital’s fees
Early Access Program (EAPs):
-
- EAP strategy development
- Conception and submission of EAP request file
- Medical Writing
- EAPs Management/Coordination
- Monitoring of vigilance
- Data Management
- Statistics
Patient Education Program (PSP):
-
- Proposition of programs
- Implementing programs
- Provision of a Call Center with trained staff coordinated by doctors
- Program analysis and report
- Management of pharmacovigilance in the context of a patient education program
Medical Writing & Publication:
-
- Bibliographic research and analysis
- Study synopsis
- Consent and patient information
- Study protocol
- Therapeutic Use Protocol (TUP) for Early Acces Program
- Case Report Form (CRF)
- Pharmacovigilance report
- Clinical Report (ICH/Non ICH)
- EAP synthesis report
- Meta-analysis
- Presentation of results: Writing of summaries, articles, posters
Management & animation of Scientific Boards:
-
-
- Selection of experts
- Signature of experts’ agreements and follow-up of declarations
- Logistical organisation of meetings
- Preparation of meeting documents
- Animation of meetings
- Management of decisions after expert’s meetings
- Interface with the sponsor
- Payment of expert’s fees
-
Education & training:
-
- KAP survey (Knowledge, Attitude, Practice) in clinical research
- Clinical Research Training (GCP-ICH)
- Training on the new European regulations
- Training in Interventional Studies Methodology
- Training in the methodology of Pharmacoepidemiology studies and Observational studies
- Pharmacovigilance training
- Training in Medical Writing and critical analysis of articles
- Training on the medical environment of the studied pathology
- Specific training adapted to the needs of each employee or customer
Data Management:
-
-
- Development of database for paper CRF & e-CRF with web access and hosting (In compliance with 21 CFR Part 11)
- Development of the Data Validation Document(DVD)
- CRF Annotation
- Data entry of paper CRF (simple or double.
- Data Clarification Form (DCF) edition
- Codification of medical data (WHOdrug and MedDRA)
- Import of external data
- Vigilance data reconciliation
- Preparation of data review meetings
- Freezing and transfer of database
- Data management report
- CDISC format (on demand)
-
Statistics:
- Development of statistical methodology and rational
- Size calculation
- Writing the statistical part of protocols
- Randomization list
- Drafting of the statistical analysis plan
- Mock report
- Programming of statistical analysis
- Calculation and statistical analysis (edition of tables and figures)
- Statistical reports : tables and figures only, with statistical interpretation of results
Market Study :
-
- Disease Management
- Prescribed volumes
- Market share by product
- Exposed populations
- Registration modalities
Market Access:
-
- Market studies
- Assessment of regulatory constraints
- Provision of local partners
- Constitution of registration dossiers
- Constitution of price records (pricing)
- Provision and management of Biosimilar projects
- Provision of Bioequivalence Centers and coordination of studies on behalf of the sponsor (price negotiation on behalf of the client)
- Access Program
Product Development Advice:
-
- Medical, methodological, clinical and statistical expertise in order to draw up a development plan according to objectives defined in terms of therapeutic indication and country
- Regulatory advice on country requirements for registration of health products and proposal of an adequate development plan
- Development of risk management plans in line with legal expectations
- Analysis of key elements allowing the negotiation of better reimbursement conditions and / or prices of health products
- Constitution of renegotiation / maintenance of price and reimbursement rate files
Regulatory affairs:
-
- Summary of Product Characteristics (SmPC) adaptation in order to ensure the conformity of your product Marketing authorization with local regulatory requirements
- Support in the submission of your Marketing Authorization file and adaptation to local regulations in the targeted countries
- Update of MA Module 3 of mature drugs regarding the evolution of regulations and manufacturing processes
Management of Vigilance:
-
- Management of Vigilance
- Case report writing (CIOMS form)
- Writing of PSUR or DSUR
- Advice on health product vigilance regulations